Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    "Hermansky Pudlak syndrome 2"
Show Display Options
Rank Status Study
1 Completed
Has Results
Treatment of HDL to Reduce the Incidence of Vascular Events HPS2-THRIVE
Conditions: Cardiovascular Disease;   Peripheral Arterial Disease;   Diabetes Mellitus;   Coronary Heart Disease
Interventions: Drug: ER niacin/laropiprant;   Drug: simvastatin;   Drug: ezetimibe/simvastatin

Indicates status has not been verified in more than two years